Robert M. Elashoff

34.4k citations

267 papers · 21.0k indexed · 9 hit papers · h-index 73

Impact in

Nephrology top 0.1%
- Parathyroid Disorders and Treatments
Oncology top 0.2%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research

Papers in

Statistics and Probability 41
- Statistical Methods and Inference 28
- Statistical Methods and Bayesian Inference 24
- Statistical Methods in Clinical Trials 17
Pathology and Forensic Medicine 49
- Systemic Sclerosis and Related Diseases 32

Co-authors: Donald L. Morton Hong Wang Jonathan Goldin Alistair J. Cochran John F. Thompson Isidro B. Salusky Barbara Gales Nicola Mozzillo
Journals: Journal of Clinical Oncology (16 papers)Journal of the American Statistical Association (13 papers)Statistics in Medicine (11 papers)American Journal of Transplantation (8 papers)Annals of the Rheumatic Diseases (8 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

Robert M. Elashoff

265 papers receiving 20.2k citations

Hit Papers

9 papers align trajectories log scale

A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops 2018 · 341 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 New England Journal of Medicine
2014 New England Journal of Medicine
2011 Gastroenterology
2006 New England Journal of Medicine
2005 Annals of Surgery
2000 New England Journal of Medicine
1999 Annals of Surgery
1983 PubMed
1974 Journal of Pharmacokinetics and Biopharmaceutics

Peers

Countries citing papers authored by Robert M. Elashoff

Since Specialization

Citations

This map shows the geographic impact of Robert M. Elashoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Elashoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Elashoff more than expected).

Fields of papers citing papers by Robert M. Elashoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Elashoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Elashoff. The network helps show where Robert M. Elashoff may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert M. Elashoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert M. Elashoff Line = papers co-authored together Robert M. Elashoff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease Annals of Surgical Oncology ·Abhineet Uppal, 裕二澤口, John F. Thompson, Leland J. Foshag, M.K. Rana, Omgo E. Nieweg, Harald J. Hoekstra, Daniel F. Roses, Vernon K. Sondak, Mohammed Kashani–Sabet, Brendon J. Coventry, Alistair J. Cochran, Manabu Fujita, Yi feng Guo, David Elashoff, Robert M. Elashoff, Mark B. Faries	2019	3
2	Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis JAMA Neurology ·Allan MacKenzie‐Graham, Florian Kurth, Yuichiro Itoh, Hong Wang, Michael Montag, Robert M. Elashoff, Rhonda R. Voskuhl	2016	23
3	Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation American Journal of Transplantation ·Michael Y. Shino, S. Samuel Weigt, L Tulejova, Ariss Derhovanessian, D. Sayah, D. B. Jones, Rajan Saggar, Aric L. Gregson, A. Ardehali, David J. Ross, Joseph P. Lynch, Robert M. Elashoff, John A. Belperio	2016	21
4	Staphylococcus via an Interaction With the ELR+ CXC Chemokine ENA-78 Is Associated With BOS American Journal of Transplantation ·Aric L. Gregson, Dean Zeldich, Patil Injean, S. Weigt, Michael Y. Shino, D. Sayah, Ariss Derhovanessian, Joseph P. Lynch, David J. Ross, Rajeev Saggar, A. Ardehali, Gang Li, Robert M. Elashoff, John A. Belperio	2015	15
5	Interaction between Pseudomonas and CXC Chemokines Increases Risk of Bronchiolitis Obliterans Syndrome and Death in Lung Transplantation American Journal of Respiratory and Critical Care Medicine ·Aric L. Gregson, Xiaoyan Wang, S. Sam Weigt, Vyacheslav Palchevskiy, Joseph P. Lynch, David J. Ross, B. Kubak, Rajan Saggar, Michael C. Fishbein, A. Ardehali, Gang Li, Robert M. Elashoff, John A. Belperio	2013	63
6	CXCR3 Ligands Are Associated with the Continuum of Diffuse Alveolar Damage to Chronic Lung Allograft Dysfunction American Journal of Respiratory and Critical Care Medicine ·Michael Y. Shino, S. Samuel Weigt, Ning Li, Vyacheslav Palchevskiy, Ariss Derhovanessian, Rajan Saggar, D. Sayah, Aric L. Gregson, Michael C. Fishbein, A. Ardehali, David J. Ross, Joseph P. Lynch, Robert M. Elashoff, John A. Belperio	2013	48
7	Longitudinal data analysis with non-ignorable missing data Statistical Methods in Medical Research ·Chi‐Hong Tseng, Robert M. Elashoff, Ning Li, Gang Li	2012	18
8	Lung Cancer Chemoprevention with Celecoxib in Former Smokers Cancer Prevention Research ·Jenny T. Mao, Michael D. Roth, Michael C. Fishbein, Denise R. Aberle, Zuo‐Feng Zhang, Jian Rao, Donald P. Tashkin, Lee Goodglick, E. Carmack Holmes, Robert B. Cameron, Steven M. Dubinett, Robert M. Elashoff, Éva Szabó, David Elashoff	2011	65
9	Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme Journal of Clinical Oncology ·Albert Lai, Anh Tran, Phioanh L. Nghiemphu, Whitney B. Pope, Orestes E. Solis, Michael T. Selch, Emese Filka, William H. Yong, Paul S. Mischel, Linda M. Liau, Surasak Phuphanich, Keith L. Black, Scott Peak, Richard M. Green, Kang June Young, Tatjana Kolevska, Jonathan Polikoff, Louis Fehrenbacher, Robert M. Elashoff, Timothy F. Cloughesy	2010	353
10	Value of the New Bone Classification System in Pediatric Renal Osteodystrophy Clinical Journal of the American Society of Nephrology ·Sevcan A. Bakkaloğlu, Katherine Wesseling‐Perry, Renata Péreira, Barbara Gales, Hong Wang, Robert M. Elashoff, Isidro B. Salusky	2010	66
11	Protection against Bronchiolitis Obliterans Syndrome Is Associated with Allograft CCR7+CD45RA− T Regulatory Cells PLoS ONE ·Aric L. Gregson, Aki Hoji, Vyacheslav Palchevskiy, Scott Hu, S. Samuel Weigt, Renal Lifecycle Trial Cardiac Imaging Sub-studies Investigators, Ariss Derhovanessian, Rajeev Saggar, Sophie X. Song, Robert M. Elashoff, Otto O. Yang, John A. Belperio	2010	32
12	Aspergillus Colonization of the Lung Allograft Is a Risk Factor for Bronchiolitis Obliterans Syndrome American Journal of Transplantation ·F. L. J. Boettcher, Robert M. Elashoff, C. Huang, A. Ardehali, Aric L. Gregson, B. Kubak, Michael C. Fishbein, Rajan Saggar, Michael P. Keane, John P. Lynch, David A. Zisman, David J. Ross, John A. Belperio	2009	141
13	Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Bone Mineralization in Children with Renal Failure on Peritoneal Dialysis The Journal of Clinical Endocrinology & Metabolism ·Katherine Wesseling‐Perry, Renata C. Pereira, Hong Wang, Robert M. Elashoff, Shobha Sahney, Barbara Gales, Harald Jüppner, Isidro B. Salusky	2008	117
14	Elevated Stress-Hemoconcentration in Major Depression Is Normalized by Antidepressant Treatment: Secondary Analysis from a Randomized, Double-Blind Clinical Trial and Relevance to Cardiovascular Disease Risk PLoS ONE ·Ma‐Li Wong, Chuanhui Dong, Karin Esposito, Sarika Thakur, Weiqing Liu, Robert M. Elashoff, Julio Licínio	2008	29
15	Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease American Journal of Respiratory and Critical Care Medicine ·Charlie Strange, Marcy B. Bolster, Michael D. Roth, Richard M. Silver, Arthur C. Theodore, Jonathan Goldin, Philip J. Clements, Joanie Chung, Robert M. Elashoff, Robert D. Suh, Edwin A. Smith, Daniel E. Furst, Donald P. Tashkin	2007	92
16	Analysis of weight loss outcomes using VLCD in black and white overweight and obese women with and without metabolic syndrome International Journal of Obesity ·Kurt Hong, Zhe Li, Haijun Wang, Robert M. Elashoff, David Heber	2005	27
17	Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement American Journal of Clinical Nutrition ·David Heber, Ian Yip, Judith Ashley, David Elashoff, Robert M. Elashoff, Vay Liang W. Go	1999	338
18	The Black American Lifestyle Intervention (BALI): The design of a weight loss program for working-class African-American women Journal of the American Dietetic Association ·Beatrice S. Kanders, Rute Isabel Rodrigues Dias Gregório, John P. Foreyt, Steven B. Heymsfield, David Heber, Robert M. Elashoff, Judith Ashley, Rebecca S. Reeves, George L. Blackburn	1994	64
19	Unpublished data summaries and the design and conduct of clinical trials Controlled Clinical Trials ·謙二野坂, George L. Blackburn, Daniel W. Nixon, Peter R. Jochimsen, Edward F. Scanlon, William Insull, I. Marilyn Buzzard, Ernst L. Wynder, Robert M. Elashoff	1989	7
20	Missing Observations in Multivariate Statistics III: Large Sample Analysis of Simple Linear Regression Journal of the American Statistical Association ·A. A. Afifi, Robert M. Elashoff	1969	51

About Robert M. Elashoff

Robert M. Elashoff is a scholar working on Statistics and Probability, Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine and Nephrology, having authored 267 papers that have together received 21.0k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (41 papers), Systemic Sclerosis and Related Diseases (32 papers), Statistical Methods and Inference (28 papers), Statistical Methods and Bayesian Inference (24 papers), Cutaneous Melanoma Detection and Management (22 papers), Statistical Methods in Clinical Trials (17 papers), Transplantation: Methods and Outcomes (16 papers) and Immunotherapy and Immune Responses (14 papers). The work is most often cited by research in Nephrology (2.4k citations), Oncology (6.8k citations), Pathology and Forensic Medicine (2.7k citations), Statistics and Probability (1.0k citations) and Dermatology (994 citations). Robert M. Elashoff has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Donald L. Morton, Hong Wang, Jonathan Goldin, Alistair J. Cochran, John F. Thompson, Isidro B. Salusky, Barbara Gales, Nicola Mozzillo, Daniel F. Roses and Constantine P. Karakousis. Their work appears in journals such as Journal of Clinical Oncology, Journal of the American Statistical Association, Statistics in Medicine, American Journal of Transplantation and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact